GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Ryman Healthcare Ltd (OTCPK:RHCGF) » Definitions » EV-to-EBITDA

Ryman Healthcare (Ryman Healthcare) EV-to-EBITDA : 13.10 (As of May. 02, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Ryman Healthcare EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Ryman Healthcare's enterprise value is $3,099.4 Mil. Ryman Healthcare's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was $236.6 Mil. Therefore, Ryman Healthcare's EV-to-EBITDA for today is 13.10.

The historical rank and industry rank for Ryman Healthcare's EV-to-EBITDA or its related term are showing as below:

RHCGF' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.64   Med: 19.97   Max: 44.09
Current: 13.69

During the past 13 years, the highest EV-to-EBITDA of Ryman Healthcare was 44.09. The lowest was 6.64. And the median was 19.97.

RHCGF's EV-to-EBITDA is ranked worse than
51.85% of 459 companies
in the Healthcare Providers & Services industry
Industry Median: 13.22 vs RHCGF: 13.69

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-02), Ryman Healthcare's stock price is $3.35. Ryman Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was $0.244. Therefore, Ryman Healthcare's PE Ratio for today is 13.73.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Ryman Healthcare EV-to-EBITDA Historical Data

The historical data trend for Ryman Healthcare's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ryman Healthcare EV-to-EBITDA Chart

Ryman Healthcare Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.05 31.41 21.47 9.20 12.91

Ryman Healthcare Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 9.20 - 12.91 -

Competitive Comparison of Ryman Healthcare's EV-to-EBITDA

For the Medical Care Facilities subindustry, Ryman Healthcare's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ryman Healthcare's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Ryman Healthcare's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Ryman Healthcare's EV-to-EBITDA falls into.



Ryman Healthcare EV-to-EBITDA Calculation

Ryman Healthcare's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=3099.429/236.587
=13.10

Ryman Healthcare's current Enterprise Value is $3,099.4 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ryman Healthcare's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was $236.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ryman Healthcare  (OTCPK:RHCGF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Ryman Healthcare's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=3.35/0.244
=13.73

Ryman Healthcare's share price for today is $3.35.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ryman Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was $0.244.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Ryman Healthcare EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Ryman Healthcare's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Ryman Healthcare (Ryman Healthcare) Business Description

Traded in Other Exchanges
Address
92 Russley Road, P.O. Box 771, Airport Business Park, Christchurch, STL, NZL, 8042
Ryman Healthcare develops, owns, and operates retirement villages and aged-care facilities in New Zealand and Australia. Most of its villages offer a combination of independent and serviced units, alongside hospital, dementia, and rest-home care. Income is predominantly earned from aged care fees, retirement unit management fees, development margins on new units, and capital gains generated when residents vacate and Ryman resells existing units.

Ryman Healthcare (Ryman Healthcare) Headlines